These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18220748)

  • 61. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes).
    Bron R; Ortiz A; Wilschut J
    Biochemistry; 1994 Aug; 33(31):9110-7. PubMed ID: 8049214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate.
    Liu X; Siegrist S; Amacker M; Zurbriggen R; Pluschke G; Seeberger PH
    ACS Chem Biol; 2006 Apr; 1(3):161-4. PubMed ID: 17163663
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery.
    Soltani F; Parhiz H; Mokhtarzadeh A; Ramezani M
    Curr Pharm Des; 2015; 21(42):6214-35. PubMed ID: 26503143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens.
    Mallick AI; Kulkarni RR; St Paul M; Parvizi P; Nagy E; Behboudi S; Sharif S
    Viral Immunol; 2012 Jun; 25(3):226-31. PubMed ID: 22512311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
    Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
    Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.
    Kammer AR; Amacker M; Rasi S; Westerfeld N; Gremion C; Neuhaus D; Zurbriggen R
    Vaccine; 2007 Oct; 25(41):7065-74. PubMed ID: 17766014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An efficient liposomal gene delivery vehicle using Sendai F/HN proteins and protamine.
    Kim HS; Kim JS; Lee YK; Koo KH; Park YS
    Cancer Gene Ther; 2008 Apr; 15(4):214-24. PubMed ID: 18259213
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Delivery of purified, functional CFTR to epithelial cells in vitro using influenza hemagglutinin.
    Scheule RK; Bagley RG; Erickson AL; Wang KX; Fang SL; Vaccaro C; O'Riordan CR; Cheng SH; Smith AE
    Am J Respir Cell Mol Biol; 1995 Sep; 13(3):330-43. PubMed ID: 7544596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improvements in gene therapy technologies.
    Kaneda Y
    Mol Urol; 2001; 5(2):85-9. PubMed ID: 11690554
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Virosome: a novel vector to enable multi-modal strategies for cancer therapy.
    Kaneda Y
    Adv Drug Deliv Rev; 2012 Jun; 64(8):730-8. PubMed ID: 21443915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The virosomal adjuvanted influenza vaccine.
    Calcagnile S; Zuccotti GV
    Expert Opin Biol Ther; 2010 Feb; 10(2):191-200. PubMed ID: 20088714
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular modeling of polynucleotide complexes.
    Meneksedag-Erol D; Tang T; Uludağ H
    Biomaterials; 2014 Aug; 35(25):7068-76. PubMed ID: 24856107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
    Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S
    Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
    Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
    Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sendai viroplexes for epidermal growth factor receptor-directed delivery of interleukin-12 and salmosin genes to cancer cells.
    Kim JS; Kim MW; Jeong HY; Kang SJ; Park SI; Lee YK; Kim HS; Kim KS; Park YS
    J Gene Med; 2016 Jul; 18(7):112-23. PubMed ID: 27191929
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.
    Cao D; Tian S; Huang H; Chen J; Pan S
    Mol Pharm; 2015 Jan; 12(1):240-52. PubMed ID: 25514347
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Use of the zwitterion detergent Sulfobetain-12 for preparation of virosomes and investigation of their immunogenic and protective properties].
    Mazhul' LA; Smirnova GV; Lotte VD; Zhigis LS; Reshetov PD
    Mol Gen Mikrobiol Virusol; 1988 Dec; (12):42-7. PubMed ID: 2855092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.